{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:25:33Z","timestamp":1780525533725,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":3849,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1194\/jlr.p001172","type":"journal-article","created":{"date-parts":[[2009,9,15]],"date-time":"2009-09-15T01:48:28Z","timestamp":1252979308000},"page":"1201-1207","source":"Crossref","is-referenced-by-count":50,"title":["Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly"],"prefix":"10.1016","volume":"51","author":[{"given":"Eliana","family":"Polisecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inga","family":"Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Packard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton J.M.","family":"de Craen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi G.J.","family":"Westendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan M.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst J.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.P001172_bib1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.298.7.776","article-title":"Clinical utility of different lipid measures for prediction of coronary heart disease in men and women","volume":"298","author":"Ingelsson","year":"2007","journal-title":"JAMA."},{"key":"10.1194\/jlr.P001172_bib2","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation."},{"key":"10.1194\/jlr.P001172_bib3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/ajcn\/49.4.629","article-title":"Cholesterol absorption: regulation of cholesterol synthesis and elimination and within population variations of serum cholesterol levels","volume":"49","author":"Miettinen","year":"1989","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1194\/jlr.P001172_bib4","series-title":"Handbook of Experimental Pharmocology","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/3-540-27661-0_7","article-title":"Plant sterols and stanols","author":"Tikkanen","year":"2005"},{"key":"10.1194\/jlr.P001172_bib5","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1194\/jlr.M200155-JLR200","article-title":"Inheritance of cholesterol metabolism of probands with high or low cholesterol absorption","volume":"43","author":"Gylling","year":"2002","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P001172_bib6","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/dmrr.697","article-title":"Markers of absorption and synthesis of cholesterol in men with type 1 diabetes","volume":"23","author":"Gylling","year":"2007","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1194\/jlr.P001172_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1006\/geno.2000.6151","article-title":"Evidence for a Niemann-pick C (NPC) gene family: identification and characterization of NPC1L1","volume":"65","author":"Davies","year":"2000","journal-title":"Genomics."},{"key":"10.1194\/jlr.P001172_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.277.5323.228","article-title":"Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis","volume":"277","author":"Carstea","year":"1997","journal-title":"Science."},{"key":"10.1194\/jlr.P001172_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.bbalip.2009.01.002","article-title":"Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter","volume":"1791","author":"Davis","year":"2009","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1194\/jlr.P001172_bib10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.1093131","article-title":"Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption","volume":"303","author":"Altmann","year":"2004","journal-title":"Science."},{"key":"10.1194\/jlr.P001172_bib11","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI30060","article-title":"Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe","volume":"117","author":"Temel","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.P001172_bib12","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1073\/pnas.0508483103","article-title":"Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels","volume":"103","author":"Cohen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.P001172_bib13","doi-asserted-by":"crossref","first-page":"8132","DOI":"10.1073\/pnas.0500269102","article-title":"The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)","volume":"102","author":"Garcia-Calvo","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.P001172_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-0004.2004.00388.x","article-title":"Compound het\u00aderozygosity for two non-synonymous polymorphisms in NPC1L1 in a non-responder to ezetimibe","volume":"67","author":"Wang","year":"2005","journal-title":"Clin. Genet."},{"key":"10.1194\/jlr.P001172_bib15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ygeno.2005.08.007","article-title":"Sequence variation in NPC1L1 and association with improved LDL-cholesterol lowering in response to ezetimibe treatment","volume":"86","author":"Simon","year":"2005","journal-title":"Genomics."},{"key":"10.1194\/jlr.P001172_bib16","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1476-511X-4-16","article-title":"NPC1L1 haplotype is associated with inter-individual variation in plasma low-density lipoprotein response to ezetimibe","volume":"4","author":"Hegele","year":"2005","journal-title":"Lipids Health Dis."},{"key":"10.1194\/jlr.P001172_bib17","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1194\/jlr.P800042-JLR200","article-title":"Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers","volume":"50","author":"van Himbergen","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P001172_bib18","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1046\/j.1365-2362.2003.01229.x","article-title":"Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment","volume":"33","author":"Miettinen","year":"2003","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1194\/jlr.P001172_bib19","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/01.ATV.20.5.1340","article-title":"Non\u00adcholesterol sterols and cholesterol lowering by long term simvastatin treatment in coronary patients:realtion to basal serum cholestanol","volume":"20","author":"Miettinen","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P001172_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1172\/JCI116666","article-title":"Effects of lovastatin and dietary cholesterol on sterol homeostasis in healthy human subjects","volume":"92","author":"Duane","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.P001172_bib21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/bmj.316.7138.1127","article-title":"Baseline serum cholestanol as predictopr of recurrent coronary events in subgroup of Scandinavian simvastatin survival study","volume":"316","author":"Miettinen","year":"1998","journal-title":"BMJ."},{"key":"10.1194\/jlr.P001172_bib22","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S0002-9149(99)00533-0","article-title":"The design of a prospective study of Pravastatin in the Elderly at Risk (PROSPER). PROSPER Study Group. PROspective Study of Pravastatin in the Elderly at Risk","volume":"84","author":"Shepherd","year":"1999","journal-title":"Am. J. Cardiol."},{"key":"10.1194\/jlr.P001172_bib23","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet."},{"key":"10.1194\/jlr.P001172_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0022-2275(20)38697-1","article-title":"A rapid micromethod for apolipoprotein E phenotyping directly in serum","volume":"28","author":"Havekes","year":"1987","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.P001172_bib25","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/clinchem\/42.11.1817","article-title":"Frequency of phenotype-genotype discrepancies at the apolipoprotein E locus in a large population study","volume":"42","author":"Lahoz","year":"1996","journal-title":"Clin. Chem."},{"key":"10.1194\/jlr.P001172_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0021-9150(94)05439-P","article-title":"Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy","volume":"113","author":"Ordovas","year":"1995","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P001172_bib27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9150(01)00410-5","article-title":"Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner","volume":"158","author":"Pedro-Botet","year":"2001","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P001172_bib28","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.ATV.16.10.1250","article-title":"Apolipoprotein E alleles and risk of coronary disease: a meta-analysis","volume":"16","author":"Wilson","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.P001172_bib29","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0021-9150(00)00570-0","article-title":"Apolipoprotein E genotype and cardiovascular disease in the Framingham Heart Study","volume":"154","author":"Lahoz","year":"2001","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P001172_bib30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/genetics\/50.4.757","article-title":"The interaction of selection and linkage. II. Optimum models","volume":"50","author":"Lewontin","year":"1964","journal-title":"Genetics."},{"key":"10.1194\/jlr.P001172_bib31","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","author":"Expert Panel","year":"2001","journal-title":"JAMA."},{"key":"10.1194\/jlr.P001172_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.76","article-title":"Newly identified loci that influence lipid concentrations and risk of coronary artery disease","volume":"40","author":"Willer","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1194\/jlr.P001172_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.atherosclerosis.2004.08.034","article-title":"Gender specific effects of estrogen receptor alpha gene haplotype on lipid response to atorvastatin: interaction with apolipoprotein AI promoter gene polymorphism","volume":"178","author":"Kajinami","year":"2005","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.P001172_bib34","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1126\/science.1131262","article-title":"Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure","volume":"314","author":"Nackley","year":"2006","journal-title":"Science."},{"key":"10.1194\/jlr.P001172_bib35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1135308","article-title":"A \u201csilent\u201d polymorphism in the MDR1 gene changes substrate specificity","volume":"315","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520410764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520410764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.P001172","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T22:09:09Z","timestamp":1637446149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520410764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0022227520410764"],"URL":"https:\/\/doi.org\/10.1194\/jlr.p001172","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}